Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Maria Gomez

Maria Gomez

Professor

Maria Gomez

A link between GIP and osteopontin in adipose tissue and insulin resistance.

Author

  • Emma Ahlqvist
  • Peter Osmark
  • Tiina Kuulasmaa
  • Kasper Pilgaard
  • Bilal Omar
  • Charlotte Brøns
  • Olga Kotova
  • Anna Zetterqvist
  • Alena Stancáková
  • Anna Jonsson
  • Ola Hansson
  • Johanna Kuusisto
  • Timothy J Kieffer
  • Tiinamaija Tuomi
  • Bo Isomaa
  • Sten Madsbad
  • Maria F Gomez
  • Pernille Poulsen
  • Markku Laakso
  • Eva Degerman
  • Jussi Pihlajamäki
  • Nils Wierup
  • Allan Vaag
  • Leif Groop
  • Valeriya Lyssenko

Summary, in English

Low grade inflammation in obesity is associated with accumulation of the macrophagederived cytokine osteopontin in adipose tissue and induction of local as well as systemic insulin resistance. Since GIP (glucose-dependent insulinotropic polypeptide) is a strong stimulator of adipogenesis and may play a role in the development of obesity, we explored whether GIP directly would stimulate osteopontin (OPN) expression in adipose tissue and thereby induce insulin resistance. GIP stimulated OPN protein expression in a dose-dependent fashion in rat primary adipocytes. The level of OPN mRNA was higher in adipose tissue of obese individuals (0.13±}0.04 vs 0.04±}0.01, P<0.05) and correlated inversely with measures of insulin sensitivity (r=-0.24, P=0.001). A common variant of the GIP receptor (GIPR) (rs10423928) gene was associated with lower amount of the exon 9 containing isoform required for transmembrane activity. Carriers of the A-allele with a reduced receptor function showed lower adipose tissue OPN mRNA levels and better insulin sensitivity. Together, these data suggest a role for GIP not only as an incretin hormone, but also as a trigger of inflammation and insulin resistance in adipose tissue. Carriers of GIPR rs10423928 A-allele showed protective properties via reduced GIP effects. Identification of this unprecedented link between GIP and OPN in adipose tissue might open new avenues for therapeutic interventions.

Department/s

  • Genomics, Diabetes and Endocrinology
  • Medicine, Lund
  • Diabetic Complications
  • Insulin Signal Transduction
  • Department of Experimental Medical Science
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2013

Language

English

Pages

2088-2094

Publication/Series

Diabetes

Volume

62

Issue

6

Document type

Journal article

Publisher

American Diabetes Association Inc.

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Diabetic Complications
  • Insulin Signal Transduction

ISBN/ISSN/Other

  • ISSN: 1939-327X